当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第21期
编号:185737
阿糖胞苷联合地西他滨治疗急性髓系白血病患者的有效性及对外周血T淋巴细胞亚群的影响
http://www.100md.com 2021年3月27日 中国医学创新 2021年第21期
     崔文婷 胡苏 黄燕

    【关键词】 急性髓系白血病 阿糖胞苷 地西他滨 T淋巴细胞亚群 血清酶

    [Abstract] Objective: To investigate the efficacy of Cytarabine combined with Decitabine in the treatment of acute myeloid leukemia and its effect on peripheral blood T lymphocyte subsets. Method: A total of 70 patients with acute myeloid leukemia admitted to our hospital from January 2015 to December 2020 were selected, and they were randomly divided into control group and study group according to number table method, 35 patients in each group. The control group was treated with Mitoxantrone combined with Cytarabine, and the study group was treated with Cytarabine combined with Decitabine. The efficacy, occurrence of ADR were compared between two groups, the peripheral blood T lymphocyte subsets (CD4+, CD8+, CD4+/CD8+), serum enzyme levels [lactate dehydrogenase (LDH), glutamyl transpeptidase (GGT), alkaline phosphatase (ALP) ......

您现在查看是摘要页,全文长 12539 字符